Novel heterocyclyl-substituted hydroxy6-phenylphenanthridines and their use as PDE4 inhibitors
Details for Australian Patent Application No. 2005223370 (hide)
International Classifications
Event Publications
19 October 2006 PCT application entered the National Phase
PCT publication WO2005/090311 Priority application(s): WO2005/090311
22 November 2007 Change of Name(s) of Applicant(s), Section 104
ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH
29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005223371-Novel assay for the separation and quantification of hemagglutinin antigens
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser